Original articlesSynthesis and evaluation of a new series of 17α-[123I]iodovinyl estradiols
Introduction
Radioiodinated estrogens have been proposed as potential probes for the detection of estrogen dependent cancers 6, 21, 22, 30, 31. The development of a successful tumor imaging agent is dependent on devising rapid synthetic routes to materials with high receptor affinity. Additionally, the radiolabeled agent must be stable toward in vivo deiodination. We first reported the use of the iodovinyl group for stabilizing radioiodine in vivo in an estradiol (1) in 1981 (18). Since that time, a wide variety of iodovinyl radiopharmaceuticals have been developed 5, 8, 9, 10, 11, 12, 26, 28 including a number of related iodovinyl estradiols 4, 7, 13, 15, 16, 17, 23, 27, 29. Interestingly, both the nature of the estrogen derivative and the synthesis of the iodovinyl group have proven to be fruitful areas of research. We prepared the majority of our iodovinyl reagents via a hydroboration/iodination sequence that was developed in our laboratory due to the chemical and physical stability of the solid vinylboronic acid intermediates (Eq. 1) (18).
(1)
The stereochemistry of the 17α substituent in the 17α-iodovinyl estradiol agent has proven to be important in the receptor binding affinity of the agent. For example, it has been demonstrated that (Z)-isomers 1, 3 such as 2 and related steroid derivatives bind to receptors more effectively than the corresponding (E)-isomers 2, 7, 14, 15, 24, 25, 29. It has been postulated that, in molecules such as 2, the large iodine atom is directed at a different (and presumably less critical) portion of the receptor than the iodine in the corresponding (E)-isomer (1). It was further postulated that the results can be rationalized by permitting the steroid binding domain of the receptor to possess an additional hydrophobic pocket that could accommodate moderately sized lipophilic moieties in that region. In an effort to probe the limits of this proposed mechanism, we prepared a series of 17α-substituted estradiols in which the stereochemical characteristics of carbons 20 and 21 were modified systematically. The (Z)- and (E)-isomers (3 and 4) were prepared along with the related alkyl (5) and alkynyl (6) derivatives. The 123I derivatives were prepared for preliminary animal uptake evaluations, which will be reported at a later date.
Section snippets
Chemistry
The synthetic strategy involved the preparation of an alkynyl estradiol derivative which could then be converted to the corresponding boronic acid. The boronic acid would then be iodinated to give the desired vinyl iodide 18, 19, 20. A stepwise approach to forming the alkynyl estradiol was used (Fig. 1). Estrone (7, R = H) was treated with excess 5-chloro-1-lithiopent-1-yne to provide the 17α-substituted-5-chloropent-1-yl estradiol 8 in 85% yield after hydrolysis. This approach allowed
Materials and methods
A 26-gauge intravenous pediatric catheter was placed into the lateral tail vein of 24 110–130 g Sprague-Dawley rats. The radiolabeled ligand was injected through the tail vein catheter and flushed with heparinized saline. At specific times, the rats were euthanized by an intravenous overdose of sodium pentobarbital. Blood samples were collected by cardiac puncture. The following organs or tissue samples were collected and weighed: heart, lung, liver, kidney, spleen, muscle, ovaries, uterus, and
Acknowledgements
We wish to thank Professor John Katzenellenbogen (University of Illinois) for graciously carrying out the binding efficiency determinations. We also wish to thank the Department of Energy and the Robert H. Cole Foundation for financial support.
References (31)
- et al.
Synthesis of (17α,20E/Z)iodovinyl testosterone derivatives as potential radioligands for androgen and progesterone receptors
J. Steroid Biochem.
(1994) Synthesis and radiochemistry of 2,4-disubstituted 17α-iodovinylestradiols
Steroids
(1994)- et al.
No carrier added [123]I-(β-D-arabenofuranosyl)-5(E)-(2-iodovinyl)uracilHigh yielding radiolabeling via organotins
Appl. Radiat. Isotopes
(1994) - et al.
Radiotoxicity of 17α-[125I]iodovinyl-11β-methoxyestradiol in MCF-7 human breast cancer cells
J. Steroid. Biochem.
(1991) - et al.
Effect of 3-methyl-branching on the myocardial retention of radioiodinated 19-iodo-18-nonadecenoic acid analogues
Int. J. Rad. App. Instrum. [B]
(1989) - et al.
Radioiodinated ligands for the estrogen receptorTissue distribution of 17α-[125I]iodovinylestradiol derivatives in normal and tumor-bearing adult female rats
Int. J. Rad. Appl. Instrum. Part B
(1990) - et al.
Estrogen receptori with 17α-[125I]iodovinyl-11β-methoxyestradiol
Int. J. Rad. Appl. Instrum. Part B
(1992) - et al.
Synthesis, receptor binding and tissue distribution of 17α-[125I]iodovinyl-11β-ethylestradiol
Nucl. Med. Biol.
(1993) - et al.
The synthesis of radiolabeled compounds via organometallic intermediates
Tetrahedron
(1989) - et al.
Estrogen receptor imaging with 17α-[125I]iodovinyl-11β-methoxyestradiol(MIVE2)-Part II. Preliminary results in patients with breast carcinoma
Int. J. Rad. Appl. Instrum. Part B
(1992)
Receptor binding and biological effects of three 125I-iodinated estrogen derivatives in human breast cancer cells
J. Steroid. Biochem.
17α-[125I]Iodovinyl-estradiol and its 3-acetateChemical synthesis in vivo distribution studies in the rat
Biochem. Pharmacol.
Labeling estrogen receptors in breast cancer
Int. J. Rad. Appl. Instrum. Part B
Synthesis receptor binding and tissue distribution of 7α- and 11β-substituted (17α,20 E) and (17α, 20Z)-21-[125I]iodo-19-norpregna-1,3,5(10), 20-tetraene-3,17-diols
J. Med. Chem.
Synthesis receptor binding and tissue distribution of (17α,20 E)- and (17α,20 Z)-21-[125]-iodo-19-norpregna-1,3,5(10),20 tetraene-3,17-diol
J. Med. Chem.
Cited by (19)
Transition-Metal-Catalyzed Cyclization of Alkenyl Iodide
2023, Advanced Synthesis and CatalysisChemoselective and stereospecific iodination of alkynes using sulfonium iodate(i) salt
2018, Organic and Biomolecular ChemistrySynthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential
2006, Applied Radiation and IsotopesAn estradiol-conjugate for radiolabelling with <sup>177</sup>Lu: An attempt to prepare a radiotherapeutic agent
2005, Bioorganic and Medicinal ChemistryIodination of organotrifluoroborates: Synthesis of vinyl and alkynyl iodides
2004, Tetrahedron Letters